The variance in the moment capacities is more than 10% more for group A
The pharmaceutical industry is developing newer and potentially cheaper or more effective molecules that target GLP-1 and associated pathways (for example, the so-called dual- and triple-agonists tirzepatide, retatutride and orfoglipon) 257,258
The efficacy of liraglutide on weight management was subsequently surpassed by semaglutide, which, when administered weekly at a dose of 2.4 mg in obese patients without diabetes, resulted in a weight reduction of 12.4% compared to placebo in the STEP 1 study [46], and a reduction of 9.4% compared to liraglutide 3.0 mg in the STEP-8 study [47]
These included erectile dysfunction, decreased libido, and orgasmic dysfunction
Disclaimer: Compounded medications are not FDA-approved but are made in accordance with compounding regulations for safety and compliance
That's not an overabundance of caution - it's exactly what the FDA's adverse event data says matters